The new premises will support drug discovery research, clinical development and commercial manufacturing.
Life sciences company Thermo Fisher Scientific has announced the opening of a new distribution centre in Bracetown, County Meath. The facility will significantly expand the organisation’s Ireland-based infrastructure.
The center was officially opened by Minister for Enterprise, Tourism and Employment Peter Burke, TD and Rory Mullen, the head of Life Sciences for IDA Ireland. The purpose-built site will increase Thermo Fisher’s in-country distribution capacity and enable the supply and storage of a broader portfolio of products to support drug discovery research, clinical development and commercial manufacturing.
Thermo Fisher has stated that the investment will strengthen the supply chain in Ireland’s fast-growing life sciences sector and enhance local access to critical materials, chemicals and temperature-sensitive products. The new centre has been optimised for sustainability, with an on-site solar system expected to generate approximately 120,000 kWh of electricity annually.
Commenting on the announcement, Claire Wallace, the president of the research and safety market division for Europe and Europe commercial at Thermo Fisher Scientific, said, “Today’s opening reflects Thermo Fisher’s long-term commitment to serving Ireland’s vibrant life sciences sector.
“By expanding our local distribution capacity, we are responding more efficiently to the needs of our customers, partnering with them to improve the quality, speed and reliability of their supply chains. The products moving through this facility support the research, development and manufacturing of therapies reaching patients around the world.”
Minister Burke added, “This significant investment by Thermo Fisher Scientific reinforces Ireland’s position as a global leader in life sciences and biopharmaceutical manufacturing.
“The new distribution centre strengthens vital supply chain infrastructure and reflects continued confidence in Ireland’s scientific talent, pro-enterprise environment and long-term strategic vision to be a world-class hub for life sciences. I welcome the positive impact this expansion will have both regionally and nationally.”
In October of last year, Thermo Fisher Scientific announced plans to pay up to $9.4bn cash to acquire drug trial data software company Clario. The acquisition gives Thermo Fisher ownership of a software platform that plays a key role in managing the clinical data from drug trials.
Don’t miss out on the knowledge you need to succeed. Sign up for the Daily Brief, Silicon Republic’s digest of need-to-know sci-tech news.
